000			01241nam a2200181Ia 4500
008			140223b2006 xxu||||| |||| 00| 0 eng d
020			_a9780849318733 _c0.00
082			_a660.6 _bPHA
245			_aPharmaceutical Biotechnology
250			_a2nd ed
260			_aLondon _bCRC Press _c2006
300			_a411p
500			_aSince the first edition of Pharmaceutical Biotechnology was introduced over a decade ago, a not so subtle shift in the meaning of the term "biotechnology" has occurred. It has come to mean something very specific, namely (in the case of pharmaceuticals) the development of drug substances with large protein and polypeptide molecules. These substances are used to manipulate cellular DNA in order to produce a required molecule that is believed to have desirable properties in the treatment of a disease. Accordingly, the second edition of this work reflects on that change of definition by including all new material that deals directly with the development of these protein-based therapeutic substances.
600			_aPharmaceutical Biotechnology _915275
700			_aGroves, Michael _eEditor _918372
942			_2ddc _cLB _k660.6 _mPHA
995			_aPharmacy Reference _eP0005618 _j660.6 _yP0005618
999			_c15999 _d15999